Write your message
Volume 16, Issue 3 (Iranian Journal of Breast Diseases 2023)                   ijbd 2023, 16(3): 4-26 | Back to browse issues page

Ethics code: ‎IR.TABRIZU.REC.1400.048


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Sari-Sarraf V, vakili J, heidaryan M. Evaluating the Efficacy Concurrent (Aerobic-Resistance) Training Program on the Circulating Inflammatory Markers in Obese Postmenopausal Women at High-Risk of Breast Cancer: A Randomized, Parallel-Controlled and One-Center Clinical Trial. ijbd 2023; 16 (3) :4-26
URL: http://ijbd.ir/article-1-1026-en.html
1- Department of Exercise Physiology, Faculty of Physical Education and Sport Sciences, University of Tabriz, Tabriz, Iran , sarraf@tabrizu‎.ac.ir‎
2- Department of Exercise Physiology, Faculty of Physical Education and Sport Sciences, University of Tabriz, Tabriz, Iran
Abstract:   (1124 Views)
Introduction: Obesity is a chronic disease induced by imbalance of energy ‎homeostasis‏ ‏which ‎has been associated with risk of menopausal estrogen-‎dependent breast cancer. The present study ‎aimed to examine the effect of 12-‎week concurrent (aerobic-resistance) training on the inflammation marker [Estradiol, Tumor Necrosis Factor-α (TNF-α), Interleukin-6(IL-6)] and ‎physical performance (VO2max, balance, flexibility and strength) in ‎obese postmenopausal women.‎
Methods: Our research was an unblinded randomized controlled clinical trial. Thirty sedentary and obese postmenopausal women were recruited [age 45–55years, overweight or obese (BMI >25 kg/m2), and inactive (<150 min/week of physical activity) and had an elevated Gail 5-year risk score of breast cancer (>1.66%)] and randomly divided into concurrent training (CT, n=12) and control group (CG, n=13).The ‎participant’s ‎took part in a 12-week supervised intervention training 5 days/week, (each session ‎of which ‎involved 60 minutes of strength training and 30 minutes of aerobic training). Blood ‎samples ‎were taken from the volunteers to measure estradiol and TNF-α and IL-6. Physical ‎function (strength, VO2max, flexibility and balance) ‎were evaluated pre, mid and post-‎intervention. Quantitative expression was evaluated using 2-∆∆ct method and REST software.  ‎ANOVA tests ‎with Bonferroni correction were used to compare the groups at a significance level ‎of α<0.05.‎
Results: In response to training, total fat mass (FM) , ‏lean body mass(LBM) and ‏waist circulation(WC)‏ ‏in the concurrent training group improved significantly compared with the control group (P < 0.05). The CT group experienced a reduction in FM (-7.73%; ‎P ‎‎<0.05) and an increase in LBM (2.5%; P <0.05).A significant decrease in the expression of IL-6 (P=0.004) and TNF-α (P=0.0013) was observed in the experimental group compared to the control group. There was no significant difference in estradiol levels in the experimental group compared to the control (P>0.05). VO2max (P=0.001), balance (P=0.001), strength [hand grip (32.7%), leg strength (31.4%)] and flexibility (P=0.002), in the experimental group increased significantly compared to the control group.
Conclusion: The concurrent training and exercise-induced fat mass loss appears to slow the ‎increase of pro ‎inflammatory cytokines in postmenopausal women that is an established risk ‎factor of breast cancer. ‎Thus, this study provides additional evidences to the intricate interaction ‎among estradiol, ‎inflammatory cytokines, adipose tissue and muscle mass in postmenopausal ‎women.‎
Full-Text [PDF 2000 kb]   (419 Downloads)    
Type of Study: Research | Subject: Nutrition, psychology, sport
Received: 2022/12/24 | Accepted: 2023/07/8 | Published: 2023/10/23

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Iranian Journal of Breast Diseases

Designed & Developed by: Yektaweb